American Academy of Allergy, Asthma, and Immunology
5
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
To Determine the Measurement Properties of the ACT in an African American Adolescent Population With Persistent Asthma
Role: collaborator
To Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma
Role: collaborator
To Evaluate the Use of ASTHMA IQ in a Primary Care Setting
Role: collaborator
Improving Asthma Outcomes in an Urban Pediatric Population
Role: collaborator
Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly
Role: collaborator
All 5 trials loaded